Skip to Content

Join the 'Ovarian Cancer' group to help and get support from people like you.

Ovarian Cancer News

Related terms: Cancer, Ovarian, Cancer, Ovaries

FDA Approves Avastin (bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer

Posted 3 days ago by Drugs.com

South San Francisco, CA – December 6, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin (bevacizumab), either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by Avastin alone, for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Women are said to have a ‘platinum-sensitive’ form of the disease if a relapse occurs six months or longer following the last treatment with a platinum-based chemotherapy. “With today’s approval of Avastin plus chemotherapy, women in the U.S. with recurrent, platinum-sensitive ovarian cancer now have a treatment option that showed a survival difference of more than five months compared to chemotherapy al ... Read more

Related support groups: Avastin, Ovarian Cancer, Bevacizumab, Peritoneal Cancer, Fallopian Tube Cancer

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 6 days ago by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer Collaboration study. The lifetime risk of developing cancer was one in three for men and one in four for women, the researchers said. Prostate cancer was the most common type of cancer in men (1.6 million cases), and tracheal, bronchus and lung cancer was the leading cause of cancer death in men. Breast cancer was the most common cancer for women (2.4 million cases), and the leading cause of cancer death in women. The most common cancers in children were leukemia, other neoplasms, non-Hodgkin ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Cancer, Testicular Cancer, Salivary Gland Cancer, Solid Tumors

'Magic Mushroom' Chemical Eases Cancer Patients' Despair

Posted 9 days ago by Drugs.com

THURSDAY, Dec. 1, 2016 – Cancer often leaves patients feeling that life has no meaning, a state of mind that psychiatrists call "existential distress." But two new, small studies suggest that an ingredient found in hallucinogenic "magic" mushrooms can dramatically reverse this feeling. A single dose of the man-made drug psilocybin quickly lifted spirits for most cancer patients, and the effect lasted as long as six months for many, the researchers reported. One patient described her experience as "life-changing." "In 2010, I was diagnosed with ovarian cancer," Dinah Bazer, who took part in one of the studies, said during a Wednesday media conference. "Following successful surgery and chemotherapy, I was totally consumed with anxiety and fear of recurrence for over two years," she said. "It was running my life and ruining my life." After taking psilocybin, "I was bathed in God's love, ... Read more

Related support groups: Cancer, Substance Abuse, Ovarian Cancer, Toxic Reactions Incl Drug and Substance Abuse

Does Baby Powder Cause Ovarian Cancer?

Posted 4 Nov 2016 by Drugs.com

FRIDAY, Nov. 4, 2016 – A spate of multimillion-dollar jury verdicts against consumer products giant Johnson & Johnson is shining a light on a long-simmering scientific question: Can baby powder cause ovarian cancer? A jury in St. Louis last month seemed to think so. It awarded more than $70 million to a California woman who said she used Johnson's Baby Powder for decades until her ovarian cancer diagnosis. This follows two other jury verdicts in St. Louis this year with similar awards. Currently, there are roughly 1,700 state and federal lawsuits alleging that Johnson & Johnson failed to warn the public of research linking talc-containing powders to ovarian cancer. "We deeply sympathize with the women and families impacted by ovarian cancer," Carol Goodrich, a spokeswoman for the company's consumer products unit, said in a statement. However, Johnson & Johnson maintains that its baby ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation, Talc, Sterile Powder, Sclerosol

Health Highlights: Oct. 29, 2016

Posted 30 Oct 2016 by Drugs.com

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: First Baby With Zika-Linked Microcephaly Born in Puerto Rico The first baby born with Zika-linked microcephaly has been born in Puerto Rico, health officials there said Friday. Born within the past two weeks, the newborn suffered severe birth defects and is still in the hospital, the Associated Press reported. Microcephaly, a birth defect where a baby is born with an abnormally small head and underdeveloped brain, was not detected in the fetus until the eighth month of pregnancy. The infant also has hearing and vision problems, Dr. Ana Rius, Puerto Rico's Secretary of Health, told the wire service. Authorities are investigating why the case was identified so late although the mother showed Zika symptoms in the first trimester of her pregnancy, Rius told the AP. She added that the ... Read more

Related support groups: Diarrhea, Gas, Gastrointestinal Disorders, Ovarian Cancer, Zika Virus Infection

Know Your Risk for Ovarian Cancer -- and the Symptoms

Posted 9 Sep 2016 by Drugs.com

FRIDAY, Sept. 9, 2016 – A major shift is needed in the prevention and treatment of ovarian cancer, according to a doctor who specializes in the disease. "Ovarian cancer is often diagnosed too late," said Dr. David Fishman, director of the cancer center and gynecologic oncology at NewYork-Presbyterian/Queens. "It's important for women to know their risk [of] contracting this deadly disease, and its earliest warning signs," he added. All women are at risk of ovarian cancer, and one in 75 will develop the disease, Fishman said. More than 250,000 women worldwide are diagnosed with ovarian cancer every year, and 140,000 die from it. Fishman stressed that a clean pap test does not mean a woman's ovaries are cancer-free. Pap tests diagnose cervical disease, not ovarian cancer. Some call ovarian cancer a "silent" killer. Its early symptoms are mild and easy to ignore, according to Fishman. ... Read more

Related support groups: Birth Control, Contraception, Breast Cancer, Polycystic Ovary Syndrome, Ovarian Cysts, Ovarian Cancer

FDA Warns Ovarian Cancer Tests Not Reliable

Posted 9 Sep 2016 by Drugs.com

FRIDAY, Sept. 9, 2016 – Screening tests for ovarian cancer are not reliable and should not be used, the U.S. Food and Drug Administration warns. "Despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a high number of inaccurate results," the agency said in its warning. "However, over the years, numerous companies have marketed tests that claim to screen for and detect ovarian cancer," the FDA added. But these tests may lead to delays in effective preventive treatments for high-risk women who have no symptoms, or result in unnecessary medical tests and/or surgery for those who do not have the disease, the agency noted. According to the American Cancer Society, the most common screening test is called the CA-125 blood test. In many women with ovarian cancer, ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation

FDA Medwatch Alert: Ovarian Cancer Screening Tests: Safety Communication - FDA Recommends Against Use

Posted 7 Sep 2016 by Drugs.com

ISSUE: The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The Agency is especially concerned about delaying effective preventive treatments for women who show no symptoms, but who are still at increased risk for developing ovarian cancer. Despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a high number of inaccurate results. However, over the years, numerous companies have marketed tests that claim to screen for and detect ovarian cancer. FDA is concerned that women and their physicians may be misled by such claims and rely on inaccurate results to make treatment decisions. Based on the FDA’s review of available clinical data from ovarian cancer screening trials and recommendations from h ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation

Are Birth Control Pills Tied to Decline in Ovarian Cancer Deaths?

Posted 7 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Ovarian cancer deaths are down dramatically in many parts of the world, and researchers believe the use of birth control pills may be a main reason why. The analysis of World Health Organization data found that the ovarian cancer death rate fell 16 percent in the United States and almost 8 percent in Canada between 2002 and 2012. In the European Union, the ovarian cancer death rate fell 10 percent, though some countries saw far more significant drops. The United Kingdom's ovarian cancer death rate went down by 22 percent. Denmark and Sweden each saw a drop of 24 percent in their death rate from ovarian cancer, the researchers said. Ovarian cancer deaths also decreased about 12 percent in both Australia and New Zealand. In Japan, the ovarian cancer death rate declined 2 percent, the study found. Japan has low rates of birth control use, the researchers said. ... Read more

Related support groups: Birth Control, Contraception, Ovarian Cancer

Use of Cancer-Linked Fibroid Device Declines After FDA Warning

Posted 23 Aug 2016 by Drugs.com

TUESDAY, Aug. 23, 2016 – The use of power morcellators – cutting tools used in minimally invasive gynecological procedures – has dropped significantly for hysterectomies since the U.S. Food and Drug Administration warned against their use two years ago, a new study finds. Power morcellators have small blades that rotate rapidly. When used in minimally invasive hysterectomies or for the removal of noncancerous growths on the uterus known as fibroids, they slice the tissue into smaller pieces that are removed through a small opening in the abdomen. But tiny pieces of tissue can also spread to other areas of the body. And, sometimes, undetected cancers can be cut up with the healthy tissue. If that cancerous tissue isn't completely removed, those cells can cause cancer elsewhere. That's what prompted the FDA to issue its 2014 warning, the researchers explained. The new study looked only ... Read more

Related support groups: Surgery, Cancer, Hysterectomy, Ovarian Cancer, Uterine Leiomyomata / Fibroids, Urinary Tract Cancer, Genitourinary Surgical and Other Conditions

Women's Cancer Risk Rises With Years Spent Overweight

Posted 16 Aug 2016 by Drugs.com

TUESDAY, Aug. 16, 2016 – The longer a woman is overweight, the higher her risk of several cancers, researchers report. The study, which followed nearly 74,000 U.S. women, found that the longer a woman carried excess poundage, the greater her risk of breast, endometrial, colon and kidney cancers. "We've known for a long time that excess weight is important in cancer risk," said Susan Gapstur, vice president of epidemiology for the American Cancer Society. The cancer society says excess weight contributes to as many as 20 percent of all cancer deaths. "This study is interesting because it suggests that the number of years you spend being overweight also matters," said Gapstur, who was not involved in the research. And that, she said, should provide further incentive to avoid excess weight gain in the first place. Currently, about 7 out of 10 adults in the United States are overweight, ... Read more

Related support groups: Obesity, Cancer, Breast Cancer, Weight Loss, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Bladder Cancer, Urinary Tract Cancer

Health Insurance Status May Affect Cancer Patients' Survival

Posted 8 Aug 2016 by Drugs.com

MONDAY, Aug. 8, 2016 – Two large studies suggest that surviving certain cancers in America could depend on your health insurance status. Despite improvements in cancer diagnosis and treatment, patients who were uninsured or had Medicaid coverage were more likely to suffer worse outcomes, compared with people who have other forms of health insurance, the studies found. People who were uninsured or relied on Medicaid were diagnosed at a later stage, received sub-optimal treatment and had shorter survival, the findings showed. In the case of testicular cancer, they were at greater risk of death from their disease than patients with other insurance, the researchers found. The findings, published online Aug. 8 in the journal Cancer, add to evidence linking poor outcomes and inadequate health insurance. Dr. Christopher Sweeney, a medical oncologist at the Dana-Farber Cancer Institute in ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Basal Cell Carcinoma, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic

Delirium Common in Cancer Patients Seen in ER

Posted 25 Jul 2016 by Drugs.com

MONDAY, July 25, 2016 – Delirium is fairly common, yet often missed, in advanced cancer patients who visit emergency departments, a new study says. Delirium is a serious disturbance in thinking and awareness, according to the U.S. National Cancer Institute. Researchers looked for delirium in 243 advanced cancer patients seen at an emergency department. The patients were between the ages of 19 and 89. The researchers found that 22 patients – 9 percent – had delirium. Eighteen had mild delirium and four had moderate delirium. Ten percent of the 99 patients older than 65 had delirium, compared with eight percent of the 144 patients younger than 65. This suggests that advanced cancer patients of all ages should be considered at high risk for delirium, the researchers said. ER doctors failed to diagnose delirium in nine (41 percent) of the patients with delirium, the study said. The ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Ovarian Cancer, Melanoma - Metastatic, Breast Cancer - Palliative

Cancer Patients, Doctors Often Disagree About Prognosis

Posted 15 Jul 2016 by Drugs.com

FRIDAY, July 15, 2016 – Cancer patients and their doctors often hold different opinions about the patient's chances for survival and how long he or she might live, according to a new study. And, in many cases, patients are unaware there's any misunderstanding. "First, some patients might know the doctor's prognosis estimate but the patient chooses to disagree, often because they believe other sources. And second, some patients think that their doctor agrees with their opinion about prognosis but, in fact, the doctor doesn't," said study co-author Dr. Ronald Epstein. He is a professor of family medicine, psychiatry and oncology at the University of Rochester Medical Center in New York. For the study, researchers asked 236 patients with advanced cancer about their prognosis. The 38 doctors who treated them independently said they would "not have been surprised" if their patients died ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic, Stomach Cancer, Head and Neck Cancer, Testicular Cancer, Solid Tumors

U.S. Cancer Survivors Living Longer

Posted 1 Jul 2016 by Drugs.com

FRIDAY, July 1, 2016 – As the American population ages, more older adults will survive cancer and live with other chronic conditions that will burden the health care system, U.S. government health officials report. "Increasingly, we are seeing the impact of an aging population – fueled by maturing baby boomers – on major diseases, including cancer," said lead researcher Shirley Bluethmann, a cancer prevention fellow at the U.S. National Cancer Institute. In 2016, nearly 62 percent of almost 16 million cancer survivors are aged 65 or older, the researchers said. By 2040, an estimated 73 percent of 26 million cancer survivors will be 65 or older. "This steady and dramatic growth will affect the health care system, and so is sometimes referred to as the 'silver tsunami,' " Bluethmann said. "It not only has implications for older people who are at higher risk for cancer, it also means ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Skin Cancer, Ovarian Cancer, Melanoma - Metastatic, Solid Tumors

Page 1 2 3 4 5 6 7 8 9 10 Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, Avastin, Taxol, carboplatin, cisplatin, Cytoxan, cyclophosphamide, paclitaxel, Gemzar, view more... doxorubicin, gemcitabine, Adriamycin, Hycamtin, topotecan, etoposide, bevacizumab, Alkeran, amifostine, Platinol, Hexalen, Lynparza, Doxil, olaparib, thiotepa, melphalan, Cytoxan Lyophilized, Adriamycin RDF, Adriamycin PFS, Thioplex, Tepadina, Platinol-AQ, Carboplatin Novaplus, Neosar, Paraplatin, Ethyol, doxorubicin liposomal, dactinomycin, altretamine, Cosmegen, Toposar, Etopophos, VePesid, Onxol